To check the effectiveness and safety of blood sugar care programs in the management of high blood glucose patients.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/08/057086
- Lead Sponsor
- Dr. Reddys Laboratories Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 297
1. Adult patients (=18 years) diagnosed with T2DM.
2. Patients with glycated hemoglobin (HbA1c) levels = 9%
3. Patients possessing a personal Android (Google)/iOS smartphone with an active internet connection.
4. Patients who have fluency in the English language.
5. Patients who have signed the informed consent form and are willing to comply with the study protocol.
1. Patients with type 1 diabetes (T1D), gestational diabetes mellitus (GDM), latent autoimmune diabetes in adults (LADA), and maturity-onset diabetes of the young (MODY)
2. Patients with visual impairment
3. Pregnant, breastfeeding women or planning for a pregnancy in the next year
4. Patients currently enrolled in other clinical studies or participated in any clinical study in the last 6 months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.